Drewniak Tomasz, Rzepecki Maciej, Juszczak Kajetan, Kwiatek Wojciech, Bielecki Jakub, Zieliński Krzysztof, Ruta Andrzej, Czekierda Łukasz, Moczulskis Zbigniew
Oddział Urologii, Szpital Specjalistyczny im. Ludwika Rydygiera, Kraków.
Folia Med Cracov. 2011;51(1-4):77-90.
The main problem in nephron sparing surgery (NSS) is to preserve renal tumors oncological purity during the removal of the tumor with a margin of macroscopically unchanged kidney tissue while keeping the largest possible amount of normal parenchyma of the operated kidney. The development of imaging techniques, in particular IGT (Image Guided Therapy) allows precise imaging of the surgical field and, therefore, is essential in improving the effectiveness of NSS (increase of nephron sparing with the optimal radicality).
The aim of this study was to develop a method of the three-dimensional (3D) imaging of the kidney tumor and its lodge in the operated kidney using 3D laser scanner during NSS procedure. Additionally, the animal model of visualization was developed.
The porcine kidney model was used to test the set built up with HD cameras and linear laser scanner connected to a laptop with graphic software (David Laser Scanner, Germany) showing the surface of the kidney and the lodge after removal the chunk of renal parenchyma. Additionally, the visualization and reconstruction was performed on animal porcine model. Moreover, 5 patients (3 women, 2 men) aged from 37 to 68 years (mean 56), diagnosed with kidney tumors in CT scans with a diameter of 3.7-6.9 cm (mean 4.9) were operated in our Department this year, scanning the surface during the treatment with the kidney tumor and kidney tumor after it is removed with a margin of renal tissue. In one case, the lodge of removed tumor was scanned. Dimensions in 3D reconstruction images of laser scans in the study of animal model and the images obtained intraoperatively were compared with the dimensions evaluated during preoperative CT scans, intraoperative measurements.
Three-dimensional imaging laser scanner operating field loge resected tumor and the tumor on the kidney of animal models and during NSS treatments for patients with kidney tumors is possible in real time with an accuracy of -2 mm do +9 mm (+/- 3 mm). The duration of data acquisition by laser scanner and obtain three-dimensional image of the operating field takes an average of 13 seconds +/- 2 seconds. Movements associated with breathing and heart rate did not affect on the quality of the reconstruction. The imposition of the scanned surface texture occurs in real time, allowing you to identify renal parenchymal structures such as renal cortex, pyramids, pyelo-calices complex.
Imaging control of NSS procedures is possible in animal models and in real time intraoperatively. The comparison of tumor size and the tumor lodge obtained in preoperative CT scans with the measurements during NSS procedure provide the surgeon to assess the extent of macroscopic estimation of the resection. This procedure helps the surgeon in obtaining oncological radicality with saving as much normal tissue kidney as possible. Performance of the imaging methods should be evaluated on a larger group of patients with kidney tumors eligible for NSS treatment.
保留肾单位手术(NSS)的主要问题在于,在切除肿瘤并保留肉眼无变化的肾组织边缘时,要保持肾肿瘤的肿瘤学纯净度,同时保留手术肾脏尽可能多的正常实质。成像技术的发展,尤其是图像引导治疗(IGT),能够精确显示手术视野,因此对于提高NSS的有效性(在最佳根治性的同时增加肾单位保留)至关重要。
本研究的目的是开发一种在NSS手术过程中使用三维(3D)激光扫描仪对肾肿瘤及其在手术肾脏中的位置进行成像的方法。此外,还建立了可视化动物模型。
使用猪肾模型测试由高清摄像头和线性激光扫描仪组成的设备,该设备连接到装有图形软件(德国大卫激光扫描仪)的笔记本电脑上,可显示切除肾实质块后的肾脏表面和位置。此外,还在猪动物模型上进行了可视化和重建。此外,今年在我们科室对5例年龄在37至68岁(平均56岁)的患者(3名女性,2名男性)进行了手术,这些患者在CT扫描中被诊断为肾肿瘤,直径为3.7 - 6.9厘米(平均4.9厘米),在治疗肾肿瘤期间对肾脏表面进行扫描,并在切除肿瘤及保留肾组织边缘后对肾肿瘤进行扫描。在其中一例中,对切除肿瘤的位置进行了扫描。将动物模型研究中激光扫描的三维重建图像尺寸以及术中获得的图像尺寸与术前CT扫描评估的尺寸、术中测量结果进行比较。
三维成像激光扫描仪能够实时对动物模型的手术视野、切除的肿瘤以及肾肿瘤患者NSS治疗期间的肾脏肿瘤进行成像,精度为 -2毫米至 +9毫米(±3毫米)。激光扫描仪采集数据并获得手术视野三维图像的平均时长为13秒±2秒。与呼吸和心率相关的运动不影响重建质量。扫描表面纹理的叠加实时进行,能够识别肾实质结构,如肾皮质、肾锥体、肾盂 - 肾盏复合体。
在动物模型和术中实时进行NSS手术的成像控制是可行的。将术前CT扫描中获得的肿瘤大小和肿瘤位置与NSS手术期间的测量结果进行比较,有助于外科医生评估切除的宏观估计范围。该程序有助于外科医生在尽可能保留正常肾组织的情况下实现肿瘤根治性。成像方法的性能应在更大组符合NSS治疗的肾肿瘤患者中进行评估。